J H Levy
Overview
Explore the profile of J H Levy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
1594
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shaw J, Shaw J, Li N, Grusse M, Van Dreden P, St John M, et al.
Thromb Haemost
. 2025 Jan;
PMID: 39837561
Background: A direct oral anticoagulant (DOAC) concentration threshold above which an impact on surgical hemostasis starts to occur is unknown. Thrombin generation assays (TGAs) provide a measure of the coagulation...
2.
Fischer D, Weigand M, Moss R, Veiras S, Kubel B, Garcia-Erce J, et al.
Transfusion
. 2024 Dec;
65(1):110-121.
PMID: 39654078
Background: Liberal or overtransfusion (OT) may be regarded as "inappropriate," but it is not reported as a transfusion-related adverse event. A definition of OT is lacking. OT may include overdosing...
3.
Iba T, Levy J, Wada H, Thachil J, Warkentin T, Levi M
J Thromb Haemost
. 2019 Jan;
17(2):415-419.
PMID: 30618150
No abstract available.
4.
Iba T, Levy J
J Thromb Haemost
. 2018 Dec;
17(2):283-294.
PMID: 30582882
The vascular endothelial surface is coated by the glycocalyx, a ubiquitous gel-like layer composed of a membrane-binding domain that contains proteoglycans, glycosaminoglycan side-chains, and plasma proteins such as albumin and...
5.
de Kam P, Nolte H, Good S, Yunan M, Williams-Herman D, Burggraaf J, et al.
Br J Anaesth
. 2018 Sep;
121(4):758-767.
PMID: 30236238
Background: We investigated potential for hypersensitivity reactions after repeated sugammadex administration and explored the mechanism of hypersensitivity. Methods: In this double-blind, placebo-controlled study (NCT00988065), 448 healthy volunteers were randomised to...
6.
Godier A, Greinacher A, Faraoni D, Levy J, Samama C
J Thromb Haemost
. 2018 Aug;
16(10):2113-2115.
PMID: 30091234
No abstract available.
7.
Grottke O, Schochl H, Levy J, Hunt B
Br J Anaesth
. 2018 Feb;
120(2):407-409.
PMID: 29406192
No abstract available.
8.
Iba T, Levy J
J Thromb Haemost
. 2017 Dec;
16(2):231-241.
PMID: 29193703
The inflammatory response and the activation of coagulation are two important responses in a host's defense against infection. These mechanisms do not work independently, but cooperate in a complex and...
9.
Godier A, Greinacher A, Faraoni D, Levy J, Samama C
J Thromb Haemost
. 2017 Nov;
16(1):170-174.
PMID: 29168325
No abstract available.
10.
Levy J, Moore K, Neal M, Schneider D, Marcsisin V, Ariyawansa J, et al.
J Thromb Haemost
. 2017 Nov;
16(1):54-64.
PMID: 29106076
Summary: Background Oral activated factor X inhibitors such as rivaroxaban are widely used, but specific reversal agents are lacking. Although four-factor prothrombin complex concentrate (4F-PCC) and tranexamic acid (TXA) are...